After a 22% decline year-to-date, at the current price of around $33 per share, we believe Bath & Body Works stock (NYSE: BBWI), the largest specialty home fragrance & body care product retailer ...

The FactSet consensus is for sales of $7.947 billion, implying a 0.8% decline ... Bath & Body Works was previously a part of L Brands alongside Victoria's Secret . Bath & Body Works stock has ...

Looking ahead, the company expects full-year revenue to grow modestly by 1% to 3%, with EPS projected to decline compared to the prior year. Meanwhile, Bath & Body Works exceeded analysts' EBITDA ...

Bath & Body Works reported declines in revenue and profit and issued guidance in line with Wall Street estimates. The retailer of fragrances, lotions and body cream logged net income of $453 ...

Bath & Body Works Inc BBWI reported a third-quarter FY23 sales decline of 2.7% year-on-year to $1.562 billion, marginally beating the analyst consensus estimate of $1.560 billion. Revenue from ...

Sales may still decline, but no more than 2.5% ... this would imply less than a 15x P/E ratio for Bath & Body Works stock. That's hardly expensive for a company that most analysts expect will ...

As a result, for fiscal 2023, the company expects net sales to decline 1.5 to 3.5 percent, after previously forecasting that sales would see flat to a midsingle-digit growth. Bath & Body Works ...